Analyst Consensus ?
ConsensusHold44 ratings
Bullish1125.0%
Neutral2965.9%
Bearish49.1%
FN2 Earnings Intelligence
The Travelers Companies, Inc. (TRV) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jul 21, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Jul 21, 2026 |
| BMO Capital | Market Perform | Outperform | Downgrade | Jul 21, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jul 21, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 20, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 20, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 20, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 20, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 15, 2026 |
| TD Cowen | Sell | Hold | Downgrade | Jul 13, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 9, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 8, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Outperform | Downgrade | Jul 8, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 6, 2026 |
| HSBC | Hold | Hold | Maintain | Jul 6, 2026 |
| JP Morgan | Neutral | Underweight | Upgrade | May 26, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 11, 2025 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 23, 2025 |
| Goldman Sachs | Buy | Sell | Upgrade | Jan 8, 2025 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Nov 21, 2024 |
| Roth MKM | Buy | Buy | Maintain | Oct 21, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 7, 2024 |
| William Blair | Market Perform | Outperform | Downgrade | Jun 28, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Apr 5, 2024 |
| CFRA | Buy | Hold | Upgrade | Apr 19, 2023 |
| MKM Partners | Buy | Buy | Maintain | Jan 25, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 23, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 1, 2021 |
| Buckingham Research | Neutral | Neutral | Maintain | Jan 22, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Jan 22, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Sep 18, 2019 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jun 6, 2019 |
| B. Riley Securities | Neutral | Neutral | Maintain | Aug 7, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Aug 7, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Argus Research | Buy | Buy | Maintain | Apr 26, 2018 |
| Atlantic Equities | Neutral | Underweight | Upgrade | Jan 26, 2018 |
| FBR Capital | Market Perform | Outperform | Downgrade | Feb 13, 2017 |
| Sandler O'Neill | Hold | Buy | Downgrade | Jul 28, 2014 |
| Guggenheim | Buy | Neutral | Upgrade | May 12, 2014 |
| Drexel Hamilton | Hold | Buy | Downgrade | Apr 24, 2013 |
| Sterne Agee | Neutral | Neutral | Maintain | Apr 20, 2012 |
Upside is calculated against the persisted previous close $397.22. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BMO Capital | Analyst unavailable | $379 | $368.5 | -4.6% | Jul 21, 2026 |
| Goldman Sachs | Alex Scott | $350 | $368.66 | -11.9% | Jul 20, 2026 |
| Truist Financial | Mark Hughes | $425 | $366.87 | +7.0% | Jul 20, 2026 |
| Raymond James | Gregory Peters | $430 | $368.98 | +8.3% | Jul 20, 2026 |
| Raymond James | Analyst unavailable | $307 | $368.98 | -22.7% | Jul 20, 2026 |
| Morgan Stanley | Analyst unavailable | $290 | $336.83 | -27.0% | Jul 15, 2026 |
| Piper Sandler | Paul Newsome | $340 | $339.42 | -14.4% | Jul 13, 2026 |
| Truist Financial | Mark Hughes | $395 | $337.48 | -0.6% | Jul 10, 2026 |
| Evercore ISI | Analyst unavailable | $329 | $337.48 | -17.2% | Jul 10, 2026 |
| Barclays | Alex Scott | $295 | $303.9 | -25.7% | Jun 12, 2026 |
| Seaport Global | Analyst unavailable | $322 | $306.46 | -18.9% | May 26, 2026 |
| BMO Capital | Analyst unavailable | $314 | $305.76 | -21.0% | Apr 20, 2026 |
| Goldman Sachs | Robert Cox | $304 | $283.19 | -23.5% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $317 | $284.98 | -20.2% | Jan 7, 2026 |
| Mizuho Securities | Yaron Kinar | $317 | $290.64 | -20.2% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $313 | $284.97 | -21.2% | Oct 8, 2025 |
| Wells Fargo | Elyse Greenspan | $264 | $255.99 | -33.5% | Jul 10, 2025 |
| Morgan Stanley | Bob Huang | $269 | $274.54 | -32.3% | May 19, 2025 |
| Piper Sandler | Paul Newsome | $310 | $241.51 | -22.0% | Jan 24, 2025 |
| BMO Capital | Michael Zaremski | $270 | $259.7 | -32.0% | Oct 22, 2024 |
| JMP Securities | Meyer Shields | $273 | $259.7 | -31.3% | Oct 21, 2024 |
| Roth Capital | Harry Fong | $300 | $265.45 | -24.5% | Oct 21, 2024 |
| Wells Fargo | Elyse Greenspan | $256 | $265.45 | -35.6% | Oct 21, 2024 |
| Deutsche Bank | Cave Montazeri | $277 | $264.82 | -30.3% | Oct 18, 2024 |
| RBC Capital | Mark Dwelle | $273 | $264.82 | -31.3% | Oct 18, 2024 |
| Barclays | Alex Scott | $286 | $231.42 | -28.0% | Sep 4, 2024 |
| Piper Sandler | Paul Newsome | $207 | $203.48 | -47.9% | Jul 22, 2024 |
| Goldman Sachs | Alex Scott | $196 | $203.48 | -50.7% | Jul 22, 2024 |
| CFRA | Cathy Seifert | $225 | $203.48 | -43.4% | Jul 19, 2024 |
| Evercore ISI | David Motemaden | $236 | $203.48 | -40.6% | Jul 19, 2024 |
| Morgan Stanley | Bob Huang | $210 | $203.48 | -47.1% | Jul 19, 2024 |
| BMO Capital | Michael Zaremski | $240 | $203.48 | -39.6% | Jul 19, 2024 |
| J.P. Morgan | Jimmy Bhullar | $242 | $220.6 | -39.1% | Jul 19, 2024 |
| J.P. Morgan | Stephen Tusa | $95 | $213.07 | -76.1% | Jul 15, 2024 |
| RBC Capital | Mark Dwelle | $225 | $206.58 | -43.4% | Apr 18, 2024 |
| Goldman Sachs | Alex Scott | $202 | $206.58 | -49.1% | Apr 17, 2024 |
| CFRA | Cathy Seifert | $235 | $205.25 | -40.8% | Apr 17, 2024 |
| Morgan Stanley | Bob Huang | $214 | $206.06 | -46.1% | Apr 17, 2024 |
| UBS | Brian Meredith | $225 | $223.12 | -43.4% | Apr 17, 2024 |
| Raymond James | Gregory Peters | $185 | $159.68 | -53.4% | Jul 25, 2022 |
| RBC Capital | Mark Dwelle | $165 | $156.83 | -58.5% | Jul 22, 2022 |
| Wolfe Research | Charles Lederer | $156 | $163.15 | -60.7% | Jun 22, 2022 |
| Morgan Stanley | Analyst unavailable | $184 | $176.88 | -53.7% | Apr 20, 2022 |
| RBC Capital | Mark Dwelle | $190 | $184.86 | -52.2% | Apr 9, 2022 |
| Credit Suisse | Andrew Kligerman | $178 | $166.82 | -55.2% | Jan 30, 2022 |
| Jefferies | Yaron Kinar | $176 | $161.48 | -55.7% | Jan 6, 2022 |
| Bank of America Securities | Joshua Shanker | $152 | $156.96 | -61.7% | Oct 20, 2021 |
| UBS | Brian Meredith | $158 | $154.52 | -60.2% | Oct 11, 2021 |
Track every rating change on TRV the moment it posts. Free to start.
Start free